Zynerba Pharmaceuticals to Present at Canaccord Genuity’s 36th Annual Growth Conference

DEVON, Pa., Aug. 03, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the Company will present at Canaccord Genuity’s 36th Annual Growth Conference. The conference will be held August 10 to 11, at the InterContinental Boston. Zynerba Chairman and CEO Armando Anido will present on Wednesday, August 10, at 12:00 pm Eastern Daylight Time.

Click here to read the full press release.

 


©2016 PACT All Rights Reserved